KRAS and Miyoshi myopathy: Although, according to ClinVar Database, the KRAS G13D variant presents conflicting interpretations of pathogenicity and it is not associated with MM, in vitro studies showed an increased activity of proteasome in MM cell lines expressing KRAS G13D [40,41].